-+ 0.00%
-+ 0.00%
-+ 0.00%

Vaxcyte completes enrollment in OPUS-1 and OPUS-2 Phase 3 trials of VAX-31 in about 5,300 adults

Reuters·03/23/2026 12:31:16

Please log in to view news